Free Trial
OTCMKTS:EVTCY

Evotec (EVTCY) Stock Price, News & Analysis

Evotec logo
$3.50 -0.01 (-0.28%)
As of 08/29/2025

About Evotec Stock (OTCMKTS:EVTCY)

Key Stats

Today's Range
$3.50
$3.58
50-Day Range
$3.49
$4.34
52-Week Range
$14.22
$26.57
Volume
23,954 shs
Average Volume
2,407 shs
Market Capitalization
$1.16 billion
P/E Ratio
8.54
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EVTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evotec and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EVTCY Stock News Headlines

How “Trump’s New Dollar” Could Impact Your Wealth
President Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking and savings account… With this better, more technologically advanced dollar. President Trump himself called it a "big innovation"… And said that this new form of currency represents "American brilliance at its best."tc pixel
See More Headlines

EVTCY Stock Analysis - Frequently Asked Questions

Evotec's stock was trading at $4.16 at the beginning of the year. Since then, EVTCY stock has decreased by 15.9% and is now trading at $3.50.

Evotec's stock split on the morning of Wednesday, October 20th 2021.The 3-1 split was announced on Wednesday, October 20th 2021. The newly minted shares were payable to shareholders after the market closes on Wednesday, October 20th 2021. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

Evotec subsidiaries include these companies: Central Glass Germany. GmbH, Central Glass Germany, Rigenerand Srl, GlaxoSmithKine's the Verona site, Just-Evotec Biologics, Aptuit, Cyprotex, and more.

Shares of EVTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
9/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:EVTCY
CIK
1412558
Employees
4,200
Year Founded
1993

Profitability

EPS (Trailing Twelve Months)
$0.41
Trailing P/E Ratio
8.54
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$7.14 million
Net Margins
20.85%
Pretax Margin
23.90%
Return on Equity
16.02%
Return on Assets
7.81%

Debt

Debt-to-Equity Ratio
0.53
Current Ratio
2.57
Quick Ratio
2.50

Sales & Book Value

Annual Sales
$572.16 million
Price / Sales
2.02
Cash Flow
$0.03 per share
Price / Cash Flow
105.53
Book Value
$2.52 per share
Price / Book
1.39

Miscellaneous

Outstanding Shares
330,221,000
Free Float
N/A
Market Cap
$1.16 billion
Optionable
Not Optionable
Beta
0.98

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (OTCMKTS:EVTCY) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners